Skip to main content

Clinical trial IJB_2711

A Phase 1, Open-Label, Dose-Escalation and Expansion, Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies

Cancers
Organ liver
Trial status Trial open for recruitment
Trial type
Prospective interventional
Phase Trial phase 1
Academic trial Non
Sponsor Incyte Corporate
EudraCT Identifier 2017-001153-13
ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03144661
Inclusion criteria after standard therapy
Last update

Follow us!

Support research

Support research

Research at the Institut Jules Bordet depends on your generosity. Make a donation today and join us in the fight against cancer.

Learn more